0001209191-17-031377.txt : 20170510
0001209191-17-031377.hdr.sgml : 20170510
20170510171742
ACCESSION NUMBER: 0001209191-17-031377
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170510
FILED AS OF DATE: 20170510
DATE AS OF CHANGE: 20170510
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ovid Therapeutics Inc.
CENTRAL INDEX KEY: 0001636651
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465270895
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 205 EAST 42ND STREET
STREET 2: SUITE 15-048
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 212-776-4381
MAIL ADDRESS:
STREET 1: 205 EAST 42ND STREET
STREET 2: SUITE 15-048
CITY: NEW YORK
STATE: NY
ZIP: 10017
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Werber Yaron
CENTRAL INDEX KEY: 0001704638
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38085
FILM NUMBER: 17831542
MAIL ADDRESS:
STREET 1: C/O OVID THERAPEUTICS INC.
STREET 2: 1460 BROADWAY, SUITE 15044
CITY: NEW YORK
STATE: NY
ZIP: 10036
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-10
0
0001636651
Ovid Therapeutics Inc.
OVID
0001704638
Werber Yaron
C/O OVID THERAPEUTICS INC.
1460 BROADWAY, SUITE 15044
NEW YORK
NY
10036
0
1
0
0
CBO, CFO, Sec. and Treas.
Employee Stock Option (Right to Buy)
8.50
2017-05-10
4
A
0
93022
0.00
A
2017-05-10
2027-01-19
Common Stock
93022
93022
D
100% of the shares subject to the Stock Option vested and became exercisable upon the closing of the initial public offering resulting in gross proceeds to the Issuer of $75,000,000 in accordance with its terms.
Laura Berezin, Attorney-in-Fact
2017-05-10